BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy SystemZacks Investment Research • 01/21/26
Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026Benzinga • 01/15/26
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal SystemPRNewsWire • 01/15/26
BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic DrugsPRNewsWire • 01/13/26
Waters Corporation Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WATPRNewsWire • 01/07/26
BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT TrialPRNewsWire • 01/05/26
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow CytometryPRNewsWire • 12/18/25
BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest BiotecPRNewsWire • 12/15/25
BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination TestingZacks Investment Research • 12/05/25
BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and LaboratoriesPRNewsWire • 12/04/25
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All SizesPRNewsWire • 12/03/25